This article was originally published in The Gray Sheet
Cash acquisition of diagnostic test kit and reagent-maker Meridian Diagnostics is valued at $3 per share, or roughly $43 mil. For the 12 months ended Sept. 30, 1997, the company booked net income of nearly $6 mil. on sales of $35.2 mil. Gull, a Salt Lake City-based unit of Fresenius, markets diagnostic test kits for infectious diseases and autoimmune disorders
You may also be interested in...
Arcadia prohibited from arguing against Advantice’s appeal of National Advertising Division decision that Kerasal Fungal Nail Renewal ad claims weren’t supported. Arcadia violated confidentiality rule by publicizing NAD decision before the review was officially closed.
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.